Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Charles A ButtsFrances A Shepherd

Abstract

PURPOSE Adjuvant cisplatin-based chemotherapy (ACT) is now an accepted standard for completely resected stage II and III A non-small-cell lung cancer (NSCLC). Long-term follow-up is important to document persistent benefit and late toxicity. We report here updated overall survival (OS) and disease-specific survival (DSS) data. PATIENTS AND METHODS Patients with completely resected stage IB (T2N0, n = 219) or II (T1-2N1, n = 263) NSCLC were randomly assigned to receive 4 cycles of vinorelbine/cisplatin or observation. All efficacy analyses were performed on an intention-to-treat basis. Results Median follow-up was 9.3 years (range, 5.8 to 13.8; 33 lost to follow-up); there were 271 deaths in 482 randomly assigned patients. ACT continues to show a benefit (hazard ratio [HR], 0.78; 95% CI, 0.61 to 0.99; P = .04). There was a trend for interaction with disease stage (P = .09; HR for stage II, 0.68; 95% CI, 0.5 to 0.92; P = .01; stage IB, HR, 1.03; 95% CI, 0.7 to 1.52; P = .87). ACT resulted in significantly prolonged DSS (HR, 0.73; 95% CI, 0.55 to 0.97; P = .03). Observation was associated with significantly higher risk of death from lung cancer (P = .02), with no difference in rates of death from other causes or second primary mal...Continue Reading

References

Dec 10, 1997·Journal of the National Cancer Institute·M A TuckerB E Johnson
Sep 25, 1998·Journal of the National Cancer Institute·B E Johnson
Apr 18, 2002·International Journal of Radiation Oncology, Biology, Physics·Selim FiratRoger W Byhardt
Jan 8, 2003·International Journal of Cancer. Journal International Du Cancer·C Martin TammemagiPaul Kvale
Sep 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Steven M KellerUNKNOWN Eastern Cooperative Oncology Group
Oct 2, 2003·Journal of the National Cancer Institute·Giorgio V ScagliottiUNKNOWN Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigato
Jan 14, 2004·Chest·C Martin TammemagiPaul Kvale
Jan 23, 2004·The New England Journal of Medicine·Rodrigo ArriagadaUNKNOWN International Adjuvant Lung Cancer Trial Collaborative Group
May 27, 2004·JAMA : the Journal of the American Medical Association·Jay F PiccirilloEdward L Spitznagel
Feb 17, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Peyman Sardari NiaPaul Van Schil
Jun 24, 2005·The New England Journal of Medicine·Timothy WintonUNKNOWN National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators
Apr 5, 2007·Journal of the National Cancer Institute·Sophie D FossåLois B Travis
Jan 8, 2008·Lancet·UNKNOWN Early Breast Cancer Trialists' Collaborative Group (EBCTCG)W C Wood
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre PignonUNKNOWN LACE Collaborative Group
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin Besse, Thierry Le Chevalier

❮ Previous
Next ❯

Citations

May 28, 2010·Revue de pneumologie clinique·A PaumierE Giroux Leprieur
Mar 22, 2013·International Journal of Technology Assessment in Health Care·William K EvansEdward Ng
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Besse, T Le Chevalier
Oct 6, 2010·Journal of the National Cancer Institute·Paul C BoutrosIgor Jurisica
Dec 31, 2011·Journal of Experimental & Clinical Cancer Research : CR·Maria BonomiEmilio Bria
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valerie W RuschRichard J Cote
Aug 5, 2010·The Oncologist·Randeep SanghaCharles A Butts
Apr 3, 2013·Archives of Pathology & Laboratory Medicine·Kirtee RapariaMinesh P Mehta
Mar 8, 2013·Future Medicinal Chemistry·Jenny Seligmann, Chris Twelves
Mar 26, 2013·Journal of Geriatric Oncology·Marjorie G ZaudererLee M Krug
Sep 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F RotoloUNKNOWN IALT Collaborative Group
Dec 15, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giuseppe Luigi BannaElisa Zanon
Dec 4, 2014·European Journal of Internal Medicine·Patrizia FroeschStefano Cafarotti
Nov 19, 2011·Der Internist·N ReinmuthM Reck
Oct 27, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José Manuel Trigo PérezUNKNOWN SEOM (Spanish Society for Medical Oncology)
Jul 14, 2010·Current Oncology Reports·Haiying ChengBalazs Halmos
May 28, 2013·Expert Opinion on Drug Metabolism & Toxicology·Orazio CaffoEnzo Galligioni
Nov 5, 2015·Revista Portuguesa De Pneumologia·D CoutinhoA Barroso
Jan 31, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tomonari KinoshitaMitsutomo Kohno
Feb 13, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jean-Paul SculierAnne-Pascale Meert
Jun 29, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thomas E StinchcombeRamaswamy Govindan
Mar 26, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Petra MartinFrances A Shepherd
Aug 19, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shair AhmedThomas Ng
May 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sinead CuffeFrances A Shepherd
May 18, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jung-Jyh HungYu-Chung Wu
Dec 7, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sandy D DerMing-Sound Tsao
Dec 17, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Janakiraman SubramanianRamaswamy Govindan
Aug 30, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Bríd M RyanCurtis C Harris
Jul 3, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ana I RoblesCurtis C Harris
May 14, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·John M VarlottoMalcolm M DeCamp
Nov 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ming-Sound TsaoFrances A Shepherd
Jun 29, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thomas E StinchcombeRamaswamy Govindan
Aug 7, 2013·The Annals of Thoracic Surgery·Robert E MerrittJoseph B Shrager
Aug 7, 2013·The Annals of Thoracic Surgery·Sumin ShinYoung Mog Shim
Jul 9, 2013·Cirugía española·José Carlos MenesesPablo Gámez
Aug 13, 2013·Thoracic Surgery Clinics·Celine Mascaux, Frances A Shepherd

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.